levetiracetam 15 mg/mL (Levetiracetam INJECTION, SOLUTION) 15 mg/mL

Levetiracetam 15 mg/mL injection is an anticonvulsant medication used to manage certain types of seizures. This solution is administered intravenously and is available in 100 mL bags.

Strength

15 mg/mL

Pack Size

10 BAG in 1 CARTON (25021-795-82) / 100 mL in 1 BAG

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Levetiracetam 15 mg/mL is primarily used to treat partial onset seizures in adults and children. It may also be prescribed for other types of seizures as determined by a healthcare provider. This medication works by affecting certain chemicals in the brain to prevent seizures. Levetiracetam is often used as an adjunctive therapy alongside other anticonvulsant medications.

Side Effects

Common effects of levetiracetam 15 mg/mL may include drowsiness, dizziness, and fatigue. Some individuals may experience headache, nausea, or irritability. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Precautions & Warnings

Levetiracetam 15 mg/mL should be used with caution in individuals with a history of psychiatric disorders or kidney problems. It is important to follow the prescribed dosage and administration instructions carefully. This medication should be stored at room temperature and protected from light.

Avoid Interactions

Levetiracetam 15 mg/mL may interact with other medications, including other anticonvulsants, sedatives, and drugs that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided while using this medication.

Frequently Asked Questions

Levetiracetam 15 mg/mL is used to manage certain types of seizures, including partial onset seizures, often as an adjunctive therapy.

Levetiracetam 15 mg/mL is administered intravenously as a solution.

Common side effects may include drowsiness, dizziness, fatigue, headache, nausea, and irritability.

Levetiracetam 15 mg/mL may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Levetiracetam 15 mg/mL should be stored at room temperature and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.